🇰🇷 South Korea Country × Condition
hepatocellular carcinoma Clinical Trials in South Korea
Active clinical trials for hepatocellular carcinoma with research sites in South Korea. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 4 // Recruiting: 4 Phases: Phase 2, Phase 1 // Updated: Daily
Total Trials
4
Recruiting Now
4
Country
🇰🇷 South Korea
Active Trials in South Korea (4)
NCT05763277
Recruiting
Ate-Bev Early Response Prediction Model in Advanced HCC
Enrollment
170 pts
Country
🇰🇷 South Korea
Seoul National University Hospital
View Trial → NCT06767579
Recruiting
Comparison of the Incidence of Delirium Caused by Different Anesthetic Agents in Patients Undergoing Liver Transplantation
Enrollment
350 pts
Country
🇰🇷 South Korea
Yonsei University
View Trial → NCT07246668 Phase 2
Recruiting
A Phase II Single-Arm Clinical Study to Evaluate the Efficacy and Safety of Carbon Ion Radiotherapy With Atezolizumab and Bevacizumab Combination Therapy in Patients With Advanced Hepatocellular Carcinoma
Enrollment
52 pts
Country
🇰🇷 South Korea
Yonsei University
View Trial → NCT06478693 Phase 1
Recruiting
A Study of MT-303 in Adults With Advanced or Metastatic GPC3-Expressing Cancers, Including HCC
Enrollment
70 pts
Country
🇰🇷 South Korea
Myeloid Therapeutics
View Trial → Frequently Asked Questions
How many hepatocellular carcinoma clinical trials are active in South Korea?
There are currently 4 active clinical trials for hepatocellular carcinoma with sites in South Korea, of which 4 are actively recruiting patients.
How can I join a hepatocellular carcinoma clinical trial in South Korea?
To join a hepatocellular carcinoma clinical trial in South Korea, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in South Korea directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are hepatocellular carcinoma trials in South Korea?
Active hepatocellular carcinoma trials in South Korea span Phase 2, Phase 1. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology